Autoantibodies to IA-2 in IDDM: location of major antigenic determinants

Diabetes
B ZhangA L Notkins

Abstract

Thirty-three IDDM sera that immunoprecipitated full-length IA-2 were tested for reactivity with different fragments of the IA-2 molecule. The fragments were prepared by PCR amplification of IA-2 cDNA and by expression in a rabbit reticulocyte transcription/translation system. Whereas all 33 sera reacted with the intracellular domain (amino acid 604 to 979), none of the sera reacted with the extracellular domain of IA-2 (amino acid 31 to 577). Analysis of the reactivity of IDDM sera with the different regions of the intracellular domain showed that 94% (31 of the 33) reacted with the COOH-terminus (amino acid 771 to 979), 40% reacted with the NH2-terminus (amino acid 604 to 776), and 40% reacted with the middle portion (amino acid 692 to 875). Of the 31 sera that reacted with the COOH-terminus, 14 of these reacted only with the COOH-terminus and with no other region. Of the 13 sera that reacted with the NH2-terminus, only one reacted exclusively with the NH2-terminus. Treatments of the different domains of IA-2 with trypsin showed that only the COOH-terminus was resistant to trypsin, arguing that it is from this region of the IA-2 molecule that the 40-kDa tryptic fragment from insulinoma cells is derived. From these experiments,...Continue Reading

Citations

Mar 31, 2001·Pharmazie in unserer Zeit·T Forst
Oct 25, 2002·Diabetes/metabolism Research and Reviews·Norio AbiruKatsumi Eguch
Oct 12, 2001·Biochemical and Biophysical Research Communications·S ShimizuT Onodera
Dec 7, 2007·Journal of Structural and Functional Genomics·Steven C AlmoStephen K Burley
Dec 21, 2000·Journal of Immunological Methods·A ZavialovA Hinkkanen
Oct 27, 1998·Nature Biotechnology·M C HoneymanL C Harrison
Mar 5, 2003·Diabetes Technology & Therapeutics·William E WinterDesmond Schatz
Apr 15, 2010·Diabetes Technology & Therapeutics·Ewa PańkowskaMiroslawa Urban
Mar 24, 1998·Annual Review of Medicine·P A Gottlieb, G S Eisenbarth
Nov 28, 2007·Annual Review of Pathology·Tony E Walshe, Patricia A D'Amore
Aug 19, 2008·Veterinary Immunology and Immunopathology·L J DavisonB Catchpole
Jul 9, 2004·Biochemical and Biophysical Research Communications·Yih-Hsin ChangMichael S Lan
Apr 1, 2004·Endocrinology and Metabolism Clinics of North America·Francesco Vendrame, Peter A Gottlieb
Aug 7, 1998·Journal of Autoimmunity·M A MyersI R Mackay
May 17, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Claudio TibertiUmberto Di Mario
May 17, 2005·Diabetes/metabolism Research and Reviews·Bernd FrankeTerry J Wilkin
Sep 9, 2017·Nature Reviews. Endocrinology·Raffaella BuzzettiErnesto Maddaloni
Nov 25, 2005·Diabetes·Catherine PihokerAke Lernmark
Nov 25, 2000·Clinical and Experimental Immunology·J SeisslerW A Scherbaum
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·V Kolm-LittyJ Endl
Mar 23, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·James A DromeyMichael R Christie
Apr 22, 2021·Endocrine Reviews·Michelle SoCarla J Greenbaum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.